ArticleJournal of cellular and molecular medicine2026
RETRACTION: Fatty Acid Synthase Contributes to Epithelial-Mesenchymal Transition and Invasion of Salivary Adenoid Cystic Carcinoma Through PRRX1/Wnt/β-Catenin Pathway.
Article in Journal of cellular and molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retractionW.-L. Zhang, S.-S. Wang, Y.-P. Jiang, Y. Liu, X.-H. Yu, J.-B. Wu, K. Wang, X. Pang, P. Liao, X.-H. Liang, and Y.-L. Tang, "Fatty Acid Synthase Contributes to Epithelial-Mesenchymal Transition and Invasion of Salivary Adenoid Cystic Carcinoma Through PRRX1/Wnt/β-Catenin Pathway," Journal of Cellular and Molecular Medicine 24, no. 19 (2020): 11465-11476, https://doi.org/10.1111/jcmm.15760. The above article, published online on 20 August 2020 in Wiley Online Library (wileyonlinelibrary.com) has been retracted by agreement between the journal Editor-in-Chief, Stefan N. Constantinescu; The Foundation for Cellular and Molecular Medicine; and John Wiley and Sons Ltd. The retraction has been agreed due to concerns raised by third parties. Specifically, instances of image duplication have been identified within Figures 3A and S1. The authors have acknowledged the issues, explaining that they resulted from inaccuracies during figure assembly in manuscript preparation, and have provided the corrected data. However, further post-publication review revealed that the article lacks critical details necessary for reproducing and interpreting the findings, including the sequences for FASN-shRNA, FASN overexpression, PRRX1 overexpression, and their respective negative controls, as well as the absence of a legend for Figure S1. Finally, the article does not sufficiently reference relevant prior literature related to salivary adenoid cystic carcinoma in support of the study's rationale and to contextualize the study's findings, and some cited references have since been retracted, leaving related claims unsupported. Accordingly, the article has been retracted as the editors no longer consider the article's conclusions to be reliable. The authors disagree with the retraction decision.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.